Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

The Itpr3 gene causes a specific hair pattern in mice.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

The Trichodysplasia spinulosa virus protein can cause abnormal hair growth in mice.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

Genetic changes in specific proteins contribute to hair loss in some women of African descent.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

A mutation in the KRT71 gene causes a hair disorder by disrupting hair follicle structure and texture.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Telomere damage affects skin and hair follicle stem cells by messing up important growth signals.

Consider Sertoli-Leydig cell tumors in Peutz-Jeghers syndrome patients with adnexal masses.

Mutations in specific keratin genes cause improper hair structure in mice due to faulty keratin protein assembly.

The mTOR pathway may be involved in the development of hair follicle tumors, with higher activity in malignant tumors.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

A new gene mutation may cause cyclic thrombocytopenia by affecting platelet production.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

A gene mutation causes early keratinocyte maturation leading to hair loss in Olmsted syndrome.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

Keratin 17 gene mutations cause both steatocystoma multiplex and pachyonychia congenita type 2.

A mutation in the MAP2 gene causes reduced hair follicle density, leading to hairlessness.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

A new mutation in the KRT86 gene causes monilethrix in a Han family.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

Screening for the NUDT15 gene variant can prevent severe side effects from thiopurine drugs in East-Asian people.